Literature DB >> 33942768

A bidirectional relationship between metabolic syndrome and hypogonadism in men.

T R Bandgar1, K Thakkar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33942768      PMCID： PMC8253329          DOI： 10.4103/jpgm.JPGM_149_21

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN： 0022-3859            Impact factor:   1.476


× No keyword cloud information.
  7 in total

Review 1.  Metabolic and cardiovascular risk factors in Klinefelter syndrome.

Authors:  Matteo Spaziani; Antonio F Radicioni
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-05-26       Impact factor: 3.908

2.  Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.

Authors:  Raju A Gopal; Nikita Bothra; Shrikrishna V Acharya; Hosahithlu K Ganesh; Tushar R Bandgar; Padma S Menon; Nalini S Shah
Journal:  Endocr Pract       Date:  2010 Jul-Aug       Impact factor: 3.443

3.  Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism.

Authors:  Mehmet Ilkin Naharci; Murat Pinar; Erol Bolu; Abdullah Olgun
Journal:  Endocr Pract       Date:  2007-10       Impact factor: 3.443

4.  Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group.

Authors:  Hosahithlu K Ganesh; H A Vijaya Sarathi; Joe George; Vyankatesh K Shivane; Tushar Bandgar; Padma S Menon; Nalini S Shah
Journal:  Endocr Pract       Date:  2009 Sep-Oct       Impact factor: 3.443

5.  Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.

Authors:  D Tripathy; P Shah; R Lakshmy; K S Reddy
Journal:  Horm Metab Res       Date:  1998-10       Impact factor: 2.936

6.  Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism: A prospective longitudinal follow-up study.

Authors:  K Co Reddy; S B Yadav
Journal:  J Postgrad Med       Date:  2021 Apr-Jun       Impact factor: 1.476

7.  A placebo-controlled randomized study with testosterone in Klinefelter syndrome: beneficial effects on body composition.

Authors:  Christian Høst; Anders Bojesen; Mogens Erlandsen; Kristian A Groth; Kurt Kristensen; Anne Grethe Jurik; Niels H Birkebæk; Claus H Gravholt
Journal:  Endocr Connect       Date:  2019-09       Impact factor: 3.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.